Document Detail

Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types.
MedLine Citation:
PMID:  10567897     Owner:  NLM     Status:  MEDLINE    
To determine whether the status of human-papillomavirus (HPV) infection affects the clinical outcome of cervical carcinoma (CC), HPV genotype was prospectively determined in 94 consecutive CC cases subsequently followed for a median duration of 37.5 months. With a consensus PCR-RFLP method of HPV genotyping, 81 (86.2%) cancers were positive for HPV DNA. They were classified, according to the phylogenic similarities, into HPV-16-related (type 16, n = 45; type 31, n = 2), HPV-58-related (type 58, n = 17; type 33, n = 3; type 52, n = 2) and HPV-18-related (type 18, n = 8; type 68, n = 1) groups, and analyzed in relation to clinical outcome. The following results were observed: (i) Type-58-related HPVs were more prevalent in the old age (older than the median age of 52) group than in the young age group (41% vs. 14.6%, p = 0.045); (ii) 63% (5/8) of patients with advanced stages (III and IV) were HPV-negative, a figure much higher than that (9.3%, 8/84) of patients with early stages (stage I and II) (p = 0.002); (iii) the occurrence of adenocarcinoma or adenosquamous carcinoma was higher in the HPV-18-related group (50%) than in the HPV-16-related (33.3%) or the HPV-58-related (16.7%) groups (p = 0.024); (iv) the status of lymph-node metastasis and tumor grade did not correlate with HPV status; (v) 5-year survival rates were 90.2%, 80% and 74% for HPV-58-, HPV-16- and HPV-18-related groups, respectively (p = 0.03, after adjustment for tumor stage); (vi) in comparison with the HPV-16-related group, the relative risk of death in the HPV-58- and the HPV-18-related groups were 0.32 [95% CI, 0.07-1.49] and 1.87 [0.36-14.9] respectively. HPV genotype appears to affect the clinical behavior and outcome of cervical cancer. HPV-58-related types are prevalent in the older population, and appear to confer a favorable prognosis. Int. J. Cancer (Pred. Oncol.) 84:553-557, 1999.
H C Lai; C A Sun; M H Yu; H J Chen; H S Liu; T Y Chu
Related Documents :
11173147 - Is there a future for cell kinetic measurements using idurd or bdurd?
1310697 - Prediction of relapse or survival after resection in human hepatomas by dna flow cytome...
1913477 - Near diploid large bowel carcinomas have better five-year survival than aneuploid ones.
3598327 - Value of flow cytometric determination of ploidy as a guide to prognosis in operable re...
7895387 - Clinico-pathological correlation of t3 glottic carcinomas.
11372047 - Gemcitabine, epirubicin, and paclitaxel combinations in advanced breast cancer.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International journal of cancer. Journal international du cancer     Volume:  84     ISSN:  0020-7136     ISO Abbreviation:  Int. J. Cancer     Publication Date:  1999 Dec 
Date Detail:
Created Date:  2000-01-06     Completed Date:  2000-01-06     Revised Date:  2007-07-24    
Medline Journal Info:
Nlm Unique ID:  0042124     Medline TA:  Int J Cancer     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  553-7     Citation Subset:  IM    
Copyright Information:
Copyright 1999 Wiley-Liss, Inc.
Department of Obstetrics and Gynecology, Tri-Service General Hospital, Taipei, Taiwan, Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Age Factors
Aged, 80 and over
Follow-Up Studies
Life Tables
Middle Aged
Papillomaviridae / genetics,  isolation & purification*
Polymerase Chain Reaction
Polymorphism, Restriction Fragment Length
Uterine Cervical Neoplasms / diagnosis,  genetics,  mortality,  therapy*,  virology*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognosti...
Next Document:  Competitive polymerase chain reaction to quantify tumor cells in peripheral blood of patients with T...